CAMBRIDGE, Mass.--(BUSINESS WIRE)--July 5, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY - News), a leading RNAi therapeutics company, announced today that it was added to the Russell 3000 and Russell 2000 Indexes effective at the close of the U.S. markets on June 30, 2006.
